Yasuyuki Nagasawa, Takahiro Okumura, Yasuhiro Hara, Toru Kondo, Midori Hasegawa, Yoshihiko Ikeda, Toyoaki Murohara and Ken-ichi Hirano Hyogo College of Medicine, Department of Medicine, Division of Kidney and Dialysis 1-1,… Click to show full abstract
Yasuyuki Nagasawa, Takahiro Okumura, Yasuhiro Hara, Toru Kondo, Midori Hasegawa, Yoshihiko Ikeda, Toyoaki Murohara and Ken-ichi Hirano Hyogo College of Medicine, Department of Medicine, Division of Kidney and Dialysis 1-1, Mukogawa-Cho, Nishinomiya, Hyogo 663-8501, Japan; Department of Cardiology, Nagoya University Graduate, School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan; Laboratory of Cardiovascular Disease, Novel, Noninvasive, and Nutritional Therapeutics (CNT) and Triglyceride Research Center (TGRC), Department of Triglyceride Science, Graduate School of Medicine, Osaka University, 6-2-4, Furuedai, Suita, Osaka 565-0874, Japan; Department of Nephrology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukakecho, Toyoakeshi, Aichi 470-1192, Japan; and Division of Pathology, National Cerebral and Cardiovascular Center Hospital, Suita, Japan
               
Click one of the above tabs to view related content.